MSD in the UK
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
MSD in the UK
This section of the website is for UK healthcare professionals only. If you are not a healthcare professional, please click here.
Diabetes
Diabetes /
Therapy Areas /
Root /

Diabetes

Thank you for taking the time to visit us, for more information about our Type 2 Diabetes products, please click to either of our products below:

JANUVIA is a once daily DPP-4 inhibitor for the treatment of type 2 diabetes (T2DM) in adults

JANUVIA® (sitagliptin)

JANUVIA is a once daily DPP-4 inhibitor for the treatment of type 2 diabetes (T2DM) in adults1. How can JANUVIA benefit older people with T2DM?

Read more

JANUVIA® (sitagliptin) Prescribing Information
Great Britain & Northern Ireland [External links]

STEGLATRO is a cost efficient SGLT2i with proven efficacy in reducing HBA1C levels

STEGLATRO®▼(ertugliflozin)

STEGLATRO is a cost efficient SGLT2i with proven efficacy in reducing HBA1C levels2,3. How can STEGLATRO support your affordability challenges?

Read more

STEGLATRO®▼(ertugliflozin) Prescribing Information
Great Britain & Northern Ireland [External links]

Would you like to receive regular updates on MSD products?

By registering, you will have an MSD Connect account to access exclusive product information, and receive regular communications.
Register

References

  1. JANUVIA Summary of Product Characteristics.
  2. NHS Drug Tariff, May 2020.
  3. Terra SG et al (VERTIS MONO) Diabetes, Obesity and Metabolism. 2017 May;19(5):721-8.

GB-STE-00397 | Date of Preparation: August 2020